BI

BioInvent International ABSTO BioInvent Stock Report

Last reporting period 30 Sep, 2024

Updated 08 Nov, 2024

Last price

Market cap $B

0.293

Micro

Exchange

XSTO - Nasdaq STOCKHOLM AB

View Full Company Analysis

BioInvent Current ratio

13.4

Last period Current ratio

265%

Current ratio has increased in 5 years


What is Current ratio ?

Current ratio is the company's ability to repay all its short-term liabilities with available liquid assets. The value of 1.5 is the benchmark for Eyestock Rating calculation.

What is Current ratio ?

Current ratio is the company's ability to repay all its short-term liabilities with available liquid assets. The value of 1.5 is the benchmark for Eyestock Rating calculation.

What is Current ratio of BioInvent ?

BioInvent`s Current ratio for the last twelve months ended 2024-09-30 is 13.4

View Full Company Analysis